MedTrace Logo

Modified Suanzaoren Decoction Versus Eszopiclone for the Treatment of Chronic Insomnia Disorder

NCT06452953 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2024-06-11

No results posted yet for this study

Summary

The purpose of this study is to observe the cognitive function and clinical efficacy of modified Suanzaoren decoction and eszopiclone in the treatment of chronic insomnia disorder patients, and to investigate the possible neural mechanisms using MRI techniques.

Conditions

  • Chronic Insomnia Disorder

Interventions

DRUG

suanzaoren decoction

The Suanzaoren decoction is a Chinese herbal formula known for nourishing the blood, calming the mind, and nourishing the heart and liver

DRUG

Eszopiclone 1 mg

Eszopiclone is used in the treatment of various types of insomnia.

Sponsors & Collaborators

  • The Third Hospital of Inner Mongolia Autonomous Region

    collaborator UNKNOWN

  • Central South University

    lead OTHER

Principal Investigators

  • Wenbin Guo · Central South University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-10
Primary Completion
2023-10-31
Completion
2024-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06452953 on ClinicalTrials.gov